Congress of psychiatry

Psychopathology – traditions and perspectives
Chairs: 
Thomas Fuchs, Germany 
Sir David Goldberg, United Kingdom
Speaker: 
Andreas Heinz, Germany
ME-06 Meet-the-Expert
10:00 – 11:00
 | 
Room  M2 / M3
TOPIC 17:
 Psychotherapy
Psychotherapy – an integral part of psychiatry
Chairs: 
Ekin Sönmez, Turkey 
Anna-Karina Jakovljevic, Germany
Speaker: 
Fritz Hohagen, Germany
KN-38 (d) 
Keynote Lecture
10:00 – 11:15
 | 
Hall A8
 
TOPIC 21:
 Rehabilitation and work
 
Recovery: was wirkt.
Chairs: 
Wolfgang Gaebel, Germany 
Steffi G. Riedel-Heller, Germany
Speaker: 
Michaela Amering, Austria
Preisverleihung:  
DGPPN-Antistigma-Preis – Förderpreis zur Entstig-
matisierung psychischer Erkrankungen
Laudation: 
Wolfgang Gaebel, Germany
›
 in Kooperation mit dem Aktionsbündnis Seelische 
Gesundheit

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
SCIENTIFIC
 PROGRAMME
225
PR-08 
Presidential Symposium
10:00 – 11:30
 | 
Hall A3
 
TOPIC 9:
 Comorbidity of somatic and mental disorders, 
psychosomatics
Comorbidity of mental and physical diseases: 
moving towards an integration of psychiatry into 
medicine
Chairs: 
Norman Sartorius, Switzerland 
Paul Summergrad, USA
001
  Understanding co-morbidity: results from the 
international prevalence and treatment of diabetes 
and depression (INTERPRET-DD) study
Cathy Lloyd, United Kingdom
002
  Comorbidity – approaching integrity of psychi-
atry in clinical medicine
Nikolai Kornetov, Russia
003
  The burden of medical psychiatric comorbidity 
– a global issue
Paul Summergrad, USA
004
  The easy and the difficult of doing medical 
psychiatric comorbidity studies in China (part 1)
Wei Jing, People's Republic of China
005
  The easy and the difficult of doing medical 
psychiatric comorbidity studies in China (part 2)
Xin Yu, People's Republic of China
ST-28 (d) 
State-of-the-Art-Symposium
10:00 – 11:30
 | 
Hall  A6 / A7
 
TOPIC 7:
 Personality disorders
 
Borderline-Persönlichkeitsstörungen
Chairs: 
Martin Bohus, Germany 
Klaus Lieb, Germany
001
  Epidemiologie, Ätiologie und Diagnostik der 
Borderline-Persönlichkeitsstörung
Martin Bohus, Germany
002
  Evidenzbasierte Psycho- und Pharmakotherapie 
der Borderline-Persönlichkeitsstörung
Klaus Lieb, Germany
ST-29 (d) 
State-of-the-Art-Symposium
10:00 – 11:30
 | 
Hall A4
 
TOPIC 9:
 Comorbidity of somatic and mental disorders, 
psychosomatics
 
Psychosomatische Aspekte in der Behandlung 
der Adipositas
Chairs: 
Stephan Herpertz, Germany 
Stephan Zipfel, Germany
001
  Psychosomatische Aspekte der Adipositas unter 
besonderer Berücksichtigung der Adipositas-Chirurgie
Stephan Herpertz, Germany
002
  Psychotherapie und Verhaltensmodifikation bei 
der Adipositas
Stephan Zipfel, Germany
S-362 Symposium
10:00 – 11:30
 | 
Hall A1
 
TOPIC 3:
 Psychotic disorders
Autoimmune encephalitis and NMDA-receptor 
antibodies in schizophrenia: current knowledge and 
future perspectives
Chairs: 
Johann Steiner, Germany 
Peter Falkai, Germany
001
  Diagnostic and therapeutic dilemmas inherent 
to neuropsychiatric disorders associated with neu-
roinflammation or autoimmune dysfunction
Souhel Najjar, USA
002
  Antineuronal antibodies against neurotransmit-
ter receptors and synaptic proteins in schizophrenia
Johann Steiner, Germany
Thomas Frodl, Bernhard Bogerts
003
  Neurocognitive phenotype and imaging abnor-
malities of patients with NMDAR antibodies
Carsten Finke, Germany
004
  The diagnosis and management of autoimmune 
encephalitis in psychiatric settings
Belinda Lennox, United Kingdom
S-363 Symposium
10:00 – 11:30
 | 
Hall A2
 
TOPIC 32:
 Violence and trauma
Refugee women are at risk
›
 WPA Section: Transcultural Psychiatry
Chairs: 
Meryam Schouler-Ocak, Germany 
Helen Herrman, Australia
001
  Gender and trauma
Inci User, Turkey

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
SCIENTIFIC
 PROGRAMME
226
002
  Sexual violations a particular problem among 
female refugees
Marianne C. Kastrup, Denmark
003
  Health care services for female refugees in 
Australia
Kym Jenkins, Australia
004
  Results of a representative study: expectations 
of female refugees
Meryam Schouler-Ocak, Germany
S-364 Symposium
10:00 – 11:30
 | 
Hall Helsinki 1
 
TOPIC 6:
 Eating disorders, sleep disorders and other 
disorders of this category
New developments in the treatment of eating  
disorders over the life span
Chairs: 
Beate Herpertz-Dahlmann, Germany 
Ulrike Schmidt, United Kingdom
001
  Treatment setting matters – advantages and 
disadvantages of inpatient, day patient and home 
treatment in young patients with AN
Beate Herpertz-Dahlmann, Germany
002
  Repetitive transcranial magnetic stimulation: 
new hope for patients with severe and enduring 
anorexia nervosa?
Ulrike Schmidt, United Kingdom
003
  Eating disorders and impulse related disorders: 
shared vulnerabilities and management strategies
Fernando Fernández-Aranda, Spain
Susana Jimenez-Murcia
004
  Attention deficit hyperactivity disorder, binge 
eating disorder and obesity
Martina de Zwaan, Germany
S-365 Symposium
10:00 – 11:30
 | 
Hall Paris 2
 
TOPIC 3:
 Psychotic disorders
Exercise interventions in schizophrenia – promoting 
recovery and disentangling underlying pathophys-
iology
Chairs: 
Hilleke Hulshoff Pol, The Netherlands 
Berend Malchow, Germany
001
  Effects of early life physical activity patterns on 
psychosis risk
Elina Sormunen, Turkey
002
  Impaired cardiac response to incremental  
exercise in patients with schizophrenia
Karl-Jürgen Bär, Germany
003
  Feasibility and efficacy of aerobic endurance 
training interventions in patients with schizophrenia
Berend Malchow, Germany
004
  Changes in brain connectivity after endurance 
training in patients with schizophrenia
Hilleke Hulshoff Pol, The Netherlands
S-366 Symposium
10:00 – 11:30
 | 
Hall New York 1
 
TOPIC 3:
 Psychotic disorders
The Soteria paradigm as an approach to reduce 
doses of neuroleptic treatment
Chairs: 
Martin Voss, Germany 
Jürgen Gallinat, Germany
001
  Why we need to search for new strategies to 
reduce doses of neuroleptic treatment
Volkmar Aderhold, Germany
002
  Introduction to the Soteria paradigm
Holger Hoffmann, Switzerland
003
  Neurobiological mechanisms of the Soteria 
paradigm
Jürgen Gallinat, Germany
004
  Evidence for reduction of neuroleptic doses in 
Soteria
Martin Voss, Germany
S-367 Symposium
10:00 – 11:30
 | 
Hall New York 3
 
TOPIC 13:
 Brain imaging, neurophysiology, 
neuropsychology
Neuroimaging of schizophrenia: an update
›
 WPA Section: Neuroimaging in Psychiatry
Chairs: 
Silvana Galderisi, Italy 
Lynn E. DeLisi, USA
001
  Neuroimaging and psychopathological dimen-
sions in schizophrenia
Thomas Dierks, Switzerland
002
  Neuroimaging and at-risk states
Stefan Borgwardt, Switzerland
003
  Neuroimaging and longitudinal course
Geraldo Busatto, Brazil
004
  Neuroimaging and antipsychotic treatment
Antonio Vita, Italy

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
SCIENTIFIC
 PROGRAMME
227
S-368 Symposium
10:00 – 11:30
 | 
Hall London 1
 
TOPIC 24:
 Forensic psychiatry and assessment
Forensic psychiatry in Europe, Australia and China
Chairs: 
Harald Dreßing, Germany 
Giulia Signorini, Italy
001
  Forensic psychiatry in the European Union
Hans-Joachim Salize, Germany
002
  Forensic psychiatry in Italy: past, present and 
future – lessons for foreign forensic psychiatrists
Viola Bulgari, Italy
003
  Forensic psychiatry in Australia
Olav Nielssen, Australia
004
  Forensic psychiatry in China
Xiaoping Wang, People's Republic of China
S-369 Symposium
10:00 – 11:30
 | 
Hall London 3
 
TOPIC 4:
 Affective disorders
Sleep in depression and dementia – a window to the 
brain?
›
 SGBP – Swiss Society of Biological Psychiatry
Chairs: 
Martin Hatzinger, Switzerland 
Edith Holsboer-Trachsler, Switzerland
001
  Sleep and synaptic dysfunction in depression
Anne Eckert, Switzerland
002
  Synaptic plasticity model of therapeutic sleep 
deprivation in major depression
Christoph Nissen, Switzerland
003
  Sleep and dementia
Ulrich Hemmeter, Switzerland
004
  Sleep in the prediction and course of depression
Johannes Beck, Switzerland
S-370 Symposium
10:00 – 11:30
 | 
Hall London 2
 
TOPIC 38:
 Human Rights
Prison and psychiatry – addressing torture and 
ill-treatment
›
 WPA Section: Forensic Psychiatry
›
 WPA Section: Psychological Consequences of Torture 
& Persecution
Chairs: 
Pau Perez Sales, Spain 
Norbert Konrad, Germany
001
  Standards in prison psychiatry
Norbert Konrad, Germany
002
  The torturing environment scale – a new tool 
to assess conditions in long-term detention centres 
– validation and preliminary data
Pau Perez Sales, Spain
003
  Prison suicide in Germany
Annette Opitz-Welke, Germany
004
  Mental health in prison and torture
Mariam Jishkariani, Republic of Georgia
005
  Migrants in administrative detention: how to 
better care for their mental health
Joost den Otter, Greece
S-371 Symposium
10:00 – 11:30
 | 
Room M1
TOPIC 9:
 Comorbidity of somatic and mental disorders, 
psychosomatics
How much of somatic medicine do we need in 
psychiatry?
Chairs: 
Sibylle Häfner, Germany 
Alkomiet Hasan, Germany
001
  Case 1
Yatan Pal Singh Balhara, India
002
  Case 2
Rolf Wynn, Norway
Trygve Nissen
003
  Case 3
Alkomiet Hasan, Germany
004
  Case 4
Erlend Bugge, Norway

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
SCIENTIFIC
 PROGRAMME
228
S-372 Symposium
10:00 – 11:30
 | 
Room Lindau 3
TOPIC 33:
 Rural and urban mental health
Reducing maternal suicides in low-resource set-
tings: fallacy, dream or reality?
›
 WPA Section: Psychiatry in Developing Countries
›
 WPA Section: Suicidology
›
 WPA Section: Women's Mental Health
Chairs: 
Samudra T. Kathriarachchi, Sri Lanka 
Afzal Javed, United Kingdom
Speakers: 
Imbulana Liyanage Kapilasiri Jayaratne,  
Sri Lanka 
Thilini Rajapakse, Sri Lanka 
Ranil Abeysinghe, Sri Lanka 
Dewasmika Ariyasinghe, Sri Lanka
S-373 Symposium
10:00 – 11:30
 | 
Room Lindau 6
TOPIC 8:
 Disorders closely related to childhood and 
adolescence
High-functioning autism through the lens of social 
neuroscience
Chairs: 
Leonhard Schilbach, Germany 
Bhismadev Chakrabarti, United Kingdom
001
  The developmental neurobiology of autism
Silvia Cappello, Germany
002
  Reward-dependent modulation of social  
cognitive processes in autism
Bhismadev Chakrabarti, United Kingdom
003
  Kinetics and dose-dependency of oxytocin 
effects on the social brain
René Hurlemann, Germany
004
  Interpersonal predictive coding across the 
autistic spectrum
Leonhard Schilbach, Germany
S-374 Symposium
10:00 – 11:30
 | 
Room R2
TOPIC 3:
 Psychotic disorders
Recent developments in Russian psychiatry
›
 ZONE 10: Eastern Europe
Chairs: 
Petr Morozov, Russia 
Valery Krasnov, Russia
001
  On methodological issues of psychiatry:  
controversies in contemporary understanding  
of comorbidity in psychiatry
Valery Krasnov, Russia
002
  Interrelation of mental disorders and rheuma- 
tic diseases: translating research into practice
Dmitry Veltishchev, Russia
Tatiana Lisitsyna, Oxana Kovalevskaya, Olga Seravina, 
Anton Abramkin, Pavel Ovcharov, Valery Krasnov, 
Evgeny Nasonov
003
  Comprehensive care for patients with mental 
disorders: working towards service developments
George Kostyuk, Russia
004
  Psychosocial treatments for schizophrenia: 
insights from clinical psychology
Natalia Semenova, Russia
Mayya Kulygina
S-375 Symposium
10:00 – 11:30
 | 
Room R3
TOPIC 29:
 Quality assurance in psychiatry
Using technology to respond to the mental health 
needs of refugees in Europe: mobile devices, tele-
medicine, and outcomes management
Chairs: 
Victor Buwalda, The Netherlands 
Herbert Schwager, USA
001
  The use of a telemedicine model and its logis-
tics to reach as many European refugees as possible
Davor Mucic, Denmark
002
  Smartphone ownership and interest in mobile 
apps to monitor symptoms of mental health condi-
tions
Victor Buwalda, The Netherlands
003
  Preliminary results of USA field trial on the use 
of patient-reported measures in a mobile applica-
tion, and potential uses in refugee populations
William Narrow, USA
004
  Technology to respond to mental health needs 
of refugees
Reinhard Michael Krausz, Canada
S-376 Symposium
10:00 – 11:30
 | 
Room R13
TOPIC 2:
 Mental disorders due to psychotropic 
substances, behavioural addictions
Tobacco use in psychiatry: beyond cigarettes
Chairs: 
Mahmoud El-Habiby, Egypt 
Hussien Elkholy, Egypt
001
  Waterpipe and mental illness, what we know 
and what we don't know
Mahmoud El-Habiby, Egypt
002
  Waterpipe use in patients with schizophrenia
Lobna Azzam, Egypt

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
SCIENTIFIC
 PROGRAMME
229
003
  E-cigarette – the undiscovered new guest
Hussien Elkholy, Egypt
004
  Smokeless tobacco and mental illness
Mayar Nawara, Egypt
S-377 Symposium
10:00 – 11:30
 | 
Room Lindau 2
TOPIC 9:
 Comorbidity of somatic and mental disorders, 
psychosomatics
Depression and comorbid psychiatric disorders: 
diagnostics, implications and treatment – variations 
among Asian regions
Chairs: 
Aravind Vaithiyam, India 
Takahiko Inagaki, Japan
001
  Global perspectives of depression and comorbid 
psychiatric disorders
Aravind Vaithiyam, India
002
  Depression and comorbid conditions in adults
Takahiko Inagaki, Japan
003
  Management of depression and comorbid  
psychiatric illness
Sujai Subramanian, India
004
  Depression and comorbidities in child and 
adolescents
Junicha Fujita, Japan
S-100 (d) 
Symposium (German)
10:00 – 11:30
 | 
Hall Helsinki 2
 
TOPIC 18:
 Pharmacotherapy
 
Zur Evidenzlage von Psychopharmakotherapie 
und Psychotherapie
Chairs: 
Hans-Jürgen Möller, Germany 
Gerd Laux, Germany
001
  Methodische Probleme der Evidenzbestimmung
Hans-Jürgen Möller, Germany
002
  Die Evidenzdiskussion in der Therapie der 
Depression
Gerd Laux, Germany
003
  Die Evidenzdiskussion in der Therapie der 
Angststörungen
Borwin Bandelow, Germany
004
  Wie lässt sich das Placeboproblem in den Griff 
bekommen?
Ulrich Hegerl, Germany
S-101 (d) 
Symposium (German)
10:00 – 11:30
 | 
Hall Paris 1
 
TOPIC 2:
 Mental disorders due to psychotropic 
substances, behavioural addictions
 
ADHS und Störungen durch Substanzkonsum 
– von Risikofaktoren zur Abhängigkeit und deren 
Behandlung
Chairs: 
Mathias Luderer, Germany 
Franz Moggi, Switzerland
001
  Entwicklungsverlauf der ADHS und komorbi-
den Erkrankungen: Kindheit bis junges Erwachse-
nenalter
Esther Sobanski, Germany
002
  Auswirkungen von ADHS auf den Beginn und 
die Aufrechterhaltung von Substanzkonsum und 
Substanzkonsumstörungen bei jungen Schweizer 
Männern – Ergebnisse einer großen epidemiologi-
schen Studie
Franz Moggi, Switzerland
Gerhard Gmel, Joseph Studer
003
  ADHS bei Alkoholabhängigen – hohe Prävalenz 
und die Schwierigkeiten der Diagnostik
Mathias Luderer, Germany
004
  Behandlung von ADHS bei komorbider Abhän-
gigkeit
Dominique Eich, Switzerland
S-102 (d) 
Symposium (German)
10:00 – 11:30
 | 
Room  M4 / M5
TOPIC 20:
 Prevention and health promotion
 
Potenzial der Transitionspsychiatrie für die  
Prävention schwerer psychischer Störungen
›
 DGPPN Section: Prävention psychischer Erkrankungen
Chairs: 
Andrea Pfennig, Germany 
Joachim Klosterkötter, Germany
001
  Prävention als gemeinsame Aufgabe von Kin-
der-, Jugend- und Erwachsenenpsychiatrie
Iris Hauth, Germany
002
  Prävention psychischer Störungen in der  
Adoleszenz und im jungen Erwachsenenalter
Franz Petermann, Germany
003
  Prävention schwerer psychischer Störungen in 
der Transitionspsychiatrie – Erfahrungen aus der 
alters-, fach- und diagnoseübergreifenden Früher-
kennung und Frühbehandlung
Anne Karow, Germany

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
SCIENTIFIC
 PROGRAMME
230
004
  Kopf Frei – ein gemeinsames Früherkennungs-
zentrum von Kontakt- und Beratungsstelle, Erwach-
senen-, Kinder- und Jugendpsychiatrie in Berlin
Andreas Bechdolf, Germany
S-103 (d)-PF